Tissue expression
Cell line expression
Protein structure
RFX5
Regulatory factor X5A lack of MHC-II expression results in a severe immunodeficiency syndrome called MHC-II deficiency, or the bare lymphocyte syndrome (BLS; MIM 209920). At least 4 complementation groups have been identified in B-cell lines established from patients with BLS. The molecular defects in complementation groups B, C, and D all lead to a deficiency in RFX, a nuclear protein complex that binds to the X box of MHC-II promoters. The lack of RFX binding activity in complementation group C results from mutations in the RFX5 gene encoding the 75-kD subunit of RFX (Steimle et al., 1995). RFX5 is the fifth member of the growing family of DNA-binding proteins sharing a novel and highly characteristic DNA-binding domain called the RFX motif. Multiple alternatively spliced transcript variants have been found but the full-length natures of only two have been determined. [provided by RefSeq, Jul 2008]
Top validated antibodies |
|||||
Novus Biologicals | ![]() |
2 references | Polyclonal |
|
|
Invitrogen Antibodies | ![]() |
1 references | Polyclonal |
|
|
antibodies-online | ![]() |
1 references | Polyclonal |
|
|
GeneTex | ![]() |
Polyclonal |
|
||
Proteintech Group | ![]() |
2 references | Polyclonal |
|